Oertli, M; Sundquist, M; Hitzler, I; Engler, D B; Arnold, I C; Reuter, S; Maxeiner, J; Hansson, M; Taube, C; Quiding-Järbrink, M; Müller, A (2012). DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection. Journal of Clinical Investigation, 122(3):1082-1096.
Hitzler, I; Oertli, M; Becher, B; Agger, E M; Müller, A (2011). Dendritic cells prevent rather than promote immunity conferred by a helicobacter vaccine using a mycobacterial adjuvant. Gastroenterology, 141(1):186-196.e1.
Hitzler, I. Immune mechanisms governing infection control and pathogenesis of helicobacter pylori and prospects for a human vaccine. 2011, University of Zurich, Faculty of Science.
Arnold, I C; Hitzler, I; Engler, D; Oertli, M; Agger, E M; Müller, A (2011). The C-terminally encoded, MHC class II-restricted T cell antigenicity of the helicobacter pylori virulence factor CagA promotes gastric preneoplasia. Journal of Immunology, 186(11):6165-6172.
Toller, I M; Hitzler, I; Sayi, A; Mueller, A (2010). Prostaglandin E2 prevents Helicobacter-induced gastric preneoplasia and facilitates persistent infection in a mouse model. Gastroenterology, 138(4):1455-1467.e4.
Mueller, A; Sayi, A; Hitzler, I (2009). Protective and pathogenic functions of T-cells are inseparable during the Helicobacter-host interaction. Discovery medicine, 8(41):68-73.
Sayi, A; Kohler, E; Hitzler, I; Arnold, I; Schwendener, R; Rehrauer, H; Müller, A (2009). The CD4+ T cell-mediated IFN-gamma response to Helicobacter infection is essential for clearance and determines gastric cancer risk. Journal of Immunology, 182(11):7085-7101.